Cargando…

B05 PLASMA CELL LEUKEMIA-LIKE STATUS HAS INDEPENDENT PROGNOSTIC VALUE IN THE CONTEXT OF THE SECOND REVISION OF THE INTERNATIONAL STAGING SYSTEM

Detalles Bibliográficos
Autores principales:	Hofste op Bruinink, D., Kuiper, R., van Duin, M., Cupedo, T., van der Velden, V., Hoogenboezem, R., van der Holt, B., Beverloo, B., Valent, E., Vermeulen, M., D’Agostino, M., Gay, F., Broijl, A., Avet-Loiseau, H., Munshi, N., Musto, P., Moreau, P., Zweegman, S., van de Donk, N., Sonneveld, P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Best Abstracts - Oral Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171818/ http://dx.doi.org/10.1097/01.HS9.0000936112.95843.f3

Ejemplares similares

Identification of High-Risk Multiple Myeloma With a Plasma Cell Leukemia-Like Transcriptomic Profile
por: Hofste op Bruinink, Davine, et al.
Publicado: (2022)

B07 HIGH EXPRESSION OF NUCLEAR CEREBLON IS ASSOCIATED WITH LONGER SURVIVAL IN PATIENTS WITH MULTIPLE MYELOMA TREATED WITH IMIDS
por: Wester, R., et al.
Publicado: (2023)

B01: STROMAL CELL-NEUTROPHIL INTERACTIONS PROMOTE A PRO-TUMOR ENVIRONMENT IN MULTIPLE MYELOMA
por: de Jong, M, et al.
Publicado: (2022)

B02 CARFILZOMIB AND LENALIDOMIDE-BASED THERAPY FOR THE TREATMENT OF PRIMARY PLASMA CELL LEUKEMIA: RESULTS OF THE FINAL ANALYSIS OF THE PROSPECTIVE PHASE 2 EMN12/HOVON-129 STUDY FOR PATIENTS AGED 18-65 YEARS
por: van de Donk, N., et al.
Publicado: (2023)

OAB-029: Single-cell transcriptomic analysis reveals reduction of cytotoxic NK cells in a subset of newly diagnosed multiple myeloma patients impacting outcome after daratumumab therapy
por: Tahri, Sabrin, et al.
Publicado: (2022)

P804: PLASMA CELL LEUKEMIA-LIKE TRANSCRIPTOME OF BONE MARROW PLASMA CELLS AND CIRCULATING TUMOR CELL LEVELS IN PERIPHERAL BLOOD COMPLEMENTARILY DEFINE HIGH-RISK IN NEWLY DIAGNOSED MULTIPLE MYELOMA
por: D’agostino, Mattia, et al.
Publicado: (2023)

B03 CARFILZOMIB AND LENALIDOMIDE FOR PRIMARY PLASMA CELL LEUKEMIA: FINAL RESULTS OF THE PROSPECTIVE PHASE 2 EMN12/HOVON-129 STUDY FOR PATIENTS AGED ≥66 YEARS
por: Musto, P., et al.
Publicado: (2023)

B07: SAFETY AND EFFICACY OF CILTACABTAGENE AUTOLEUCEL, A CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY DIRECTED AGAINST B-CELL MATURATION ANTIGEN IN PATIENTS WITH MULTIPLE MYELOMA AND EARLY RELAPSE AFTER INITIAL THERAPY: CARTITUDE-2 RESULTS
por: van de Donk, NWCJ, et al.
Publicado: (2022)

Standardization of flow cytometric minimal residual disease assessment in international clinical trials. A feasibility study from the European Myeloma Network
por: op Bruinink, Davine Hofste, et al.
Publicado: (2020)

Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence
por: Misund, Kristine, et al.
Publicado: (2022)

B09 CARTITUDE-2 COHORT B 18-MONTH FOLLOW-UP: CILTACABTAGENE AUTOLEUCEL (CILTA-CEL), A BCMA-DIRECTED CAR-T CELL THERAPY, IN PATIENTS WITH MULTIPLE MYELOMA (MM) AND EARLY RELAPSE AFTER INITIAL THERAPY
por: Zweegman, S., et al.
Publicado: (2023)

V-Domain Ig Suppressor of T Cell Activation (VISTA) Expression Is an Independent Prognostic Factor in Multiple Myeloma
por: Mutsaers, Pim, et al.
Publicado: (2021)

VS38c and CD38-Multiepitope Antibodies Provide Highly Comparable Minimal Residual Disease Data in Patients With Multiple Myeloma
por: Broijl, Annemiek, et al.
Publicado: (2021)

B01 Virtual reality as a teaching method for resuscitation training in undergraduate first year medical students during COVID-19 pandemic: A randomised controlled trial
por: Moll-Khosrawi, Parisa, et al.
Publicado: (2022)

A Novel Approach to Improve Health Literacy in Immigrant Communities
por: Johnson, Rhonda M., et al.
Publicado: (2019)

Treatment emergent peripheral neuropathy in the CASSIOPEIA trial
por: Fokkema, Cathelijne, et al.
Publicado: (2022)

SegmentGeometry: A Tool for Measuring Second Moment of Area in 3D Slicer
por: Huie, Jonathan M, et al.
Publicado: (2022)

Implementing California Senate Bill 493 in an Outpatient Pharmacy Within an Integrated Health System: Evaluation of the Operational and Clinical Effect of Pharmacist-Ordered Laboratory Tests
por: Delgado, Hector M., et al.
Publicado: (2020)

A CURE for a Major Challenge in Phenomics: A Practical Guide to Implementing a Quantitative Specimen-Based Undergraduate Research Experience
por: Price, S A, et al.
Publicado: (2020)

The Natural Historian's Guide to the CT Galaxy: Step-by-Step Instructions for Preparing and Analyzing Computed Tomographic (CT) Data Using Cross-Platform, Open Access Software
por: Buser, T J, et al.
Publicado: (2020)

Guidance for laboratories performing molecular pathology for cancer patients
por: Cree, Ian A, et al.
Publicado: (2014)

Lessons Learned from Using Global Outcome Measures to Assess Community Pharmacy Performance
por: Urick, Benjamin Y., et al.
Publicado: (2018)

Vitamin C for Preventing and Treating the Common Cold
por: Douglas, Robert M, et al.
Publicado: (2005)

Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial
por: Oliva, Stefania, et al.
Publicado: (2021)

Antidepressant Prevention of Postnatal Depression
por: Howard, Louise M, et al.
Publicado: (2006)

The 5Ts for Teach Back: An Operational Definition for Teach-Back Training
por: Anderson, Kathryn M., et al.
Publicado: (2020)

Statins in Patients with Chronic Kidney Disease: Evidence from Systematic Reviews and Randomized Clinical Trials
por: Navaneethan, Sankar D, et al.
Publicado: (2006)

Development of Training Curriculum to Improve Patient Communication Skills and Social Support Among Community Health Workers
por: Holcomb, Jennifer, et al.
Publicado: (2022)

Using self-monitoring technology for nutritional counseling and weight management
por: Carpenter, Chelsea A, et al.
Publicado: (2022)

Comparison of Pharmacist and Physician Managed Annual Medicare Wellness Services
por: Sewell, Mary Jean, et al.
Publicado: (2016)

Learner Verification: A Methodology to Create Suitable Education Materials
por: Chavarria, Enmanuel A., et al.
Publicado: (2021)

B04: COMBINATION OF SUBCUTANEOUS TECLISTAMAB WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM A PHASE 1B MULTICOHORT STUDY
por: Rodriguez-Otero, P, et al.
Publicado: (2022)

Development of a qualitative real-time RT-PCR assay for the detection of SARS-CoV-2: a guide and case study in setting up an emergency-use, laboratory-developed molecular microbiological assay
por: Anahtar, Melis N, et al.
Publicado: (2021)

Updated UK Recommendations for HER2 assessment in breast cancer
por: Rakha, Emad A, et al.
Publicado: (2015)

Federated learning for preserving data privacy in collaborative healthcare research
por: Loftus, Tyler J, et al.
Publicado: (2022)

B06: SUBCUTANEOUS TALQUETAMAB IN COMBINATION WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): PHASE 1B RESULTS
por: Mateos, M, et al.
Publicado: (2022)

B04 IMPLEMENTING M-PROTEIN DIAGNOSTICS IN MULTIPLE MYELOMA PATIENTS USING ULTRA-SENSITIVE TARGETED MASS SPECTROMETRY DATA AND AN OFF-THE-SHELF CALIBRATOR
por: Wijnands, C., et al.
Publicado: (2023)

How Can Doctors Help Their Patients to Return to Work?
por: Verbeek, Jos H
Publicado: (2006)

Educating the Brain to Avoid Dementia: Can Mental Exercise Prevent Alzheimer Disease?
por: Gatz, Margaret
Publicado: (2005)

Fifteen minute consultation: Managing neonatal and childhood herpes encephalitis
por: Le Doare, K, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_oa5q49mism8r71smik3lnth3ia